NCT05870956View on ClinicalTrials.gov

Burden of Nintedanib Non-adherence Among Idiopathic Pulmonary Fibrosis (IPF) Patients

CompletedOBSERVATIONAL
Enrollment

1,798

Participants

Timeline

Start Date

May 16, 2023

Primary Completion Date

June 30, 2023

Study Completion Date

June 30, 2023

Conditions
Idiopathic Pulmonary Fibrosis
Interventions
DRUG

Nintedanib

Nintedanib

Trial Locations (1)

02186

Medicus Economics, LCC, Milton

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT05870956 - Burden of Nintedanib Non-adherence Among Idiopathic Pulmonary Fibrosis (IPF) Patients | Biotech Hunter | Biotech Hunter